COVID-19 vaccine safety during the antenatal period in women with idiopathic inflammatory myopathies.

Thumbnail
Author
Gupta, Latika
Date
2022-11-12
Type
Letter/Correspondence
Keyword
COVID-19; Rheumatology; Idiopathic inflammatory myopathies; Vaccine; Safety; Antenatal care
Journal Title
Rheumatology
Metadata
Show full item record
URI
https://rwt.dspace-express.com/handle/20.500.12687/1348
DOI
https://doi.org/10.1093/rheumatology/keac644
Abstract
No abstract available.
Citation
Andreoli L, Sen P, Lini D, Vincze MN, Schreiber K; COVAD Study Group, Agarwal V, Aggarwal R, Gupta L. COVID-19 vaccine safety during the antenatal period in women with idiopathic inflammatory myopathies. Rheumatology (Oxford). 2022 Nov 12:keac644. doi: 10.1093/rheumatology/keac644. Epub ahead of print. PMID: 36370070.
Publisher Link
https://academic.oup.com/rheumatology/advance-article/doi/10.1093/rheumatology/keac644/6825308?login=false
Rights
Attribution-NonCommercial 3.0 United States
Collections

The following license files are associated with this item:

Attribution-NonCommercial 3.0 United States
Except where otherwise noted, this item's license is described as Attribution-NonCommercial 3.0 United States